Brady W. Dougan, Director, 10% Owner at Humacyte, Inc. (HUMA), bought 10,000 shares at $2.54 ($25K) on 2022-12-15, disclosed to the SEC on 2022-12-19.
Open-market purchase of $25k HUMA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| HUMA | SELL | 2024-11-20 | $13.2M | — | Filing → |
| HUMA | SELL | 2024-09-11 | $4.7M | — | Filing → |
| HUMA | BUY | 2024-09-03 | $8K | — | Filing → |